Terry and Garry dive into the fascinating world of GLP-1 receptor agonists, those tiny molecules that can be both a blessing and a potential risk factor when it comes to anesthesia. In this episode, we're going embark on a journey through the world of diabetes management, how it intersects with the realm of anesthesia and what the implications are for providers in the operating room. And in the perioperative period, we're going to shine a spotlight on these new agents, explore their effects, and we're going to discuss the challenges they present to our CRNA colleagues. Here’s some of what we discuss in this episode: How SGLT2 inhibitors help with diabetes management. The basics of the GLP-1 receptor agonists. Examples of GLP-1 receptor agonists on the market today. Anesthesia considerations that need to be addressed. Unpacking Cyclopentenophenanthrene. Looking at the study: Characteristics and outcomes of patients hospitalized following a pulmonary aspiration. Visit us online and get show resources here: https://beyondthemaskpodcast.com/ Get the CE Certificate here: https://beyondthemaskpodcast.com/wp-content/uploads/2020/04/Beyond-the-Mask-CE-Cert-FILLABLE.pdf Help us grow by leaving a review: https://podcasts.apple.com/us/podcast/beyond-the-mask-innovation-opportunities-for-crnas/id1440309246

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related